Figure 2.

Primary graft failure. Flow of patients according to baseline MFI and desensitization therapy. MFI, mean fluorescence intensity; DSA, Donor specific antibodies; GF, Graft failure; Pt, patient; MDS-EB, myelodysplastic syndrome with excess blasts; CR, complete remission; AML, acute myeloid leukemia; T-MDS, therapy-related MDS; TNC, total nucleated count; MAC, myeloablative conditioning; RIC, reduced intensity conditioning; RTX, rituximab; IVIG, intravenous immunoglobulins; TPE, therapeutic plasma exchange; IS, immunosuppressors; HSCT, hematopoietic stem cell transplantation; CNS, central nervous system; LFU, last follow-up.